Sandra Milligan - 03 May 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of Research & Development
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Issuer symbol
OGN
Transactions as of
03 May 2022
Net transactions value
-$75,429
Form type
4
Filing time
05 May 2022, 20:47:48 UTC
Previous filing
03 May 2022
Next filing
15 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +1,842 +17% 12,578 03 May 2022 Direct F1
transaction OGN Common Stock Tax liability $16,842 -525 -4.2% $32.08 12,053 03 May 2022 Direct
transaction OGN Common Stock Options Exercise +4,984 +41% 17,037 04 May 2022 Direct F1
transaction OGN Common Stock Tax liability $58,587 -1,806 -11% $32.44 15,231 04 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -1,842 -50% $0.000000 1,842 03 May 2022 Common Stock 1,842 Direct F1
transaction OGN Restricted Stock Units Options Exercise $0 -4,984 -50% $0.000000 4,984 04 May 2022 Common Stock 4,984 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2 The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.
F3 On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024.